SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 2

Demographic and clinical characteristics of children with autosomal dominant polycystic kidney disease: a single center experience

Belde KASAP DEMİR
Demet ALAYGUT
Caner ALPARSLAN
Eren SOYALTIN
Fatma MUTLUBAŞ
Seçil ARSLANSOYU ÇAMLAR
Önder YAVAŞCAN
Merve ARYA
Afig BERDELİ
Pages
772–777
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The demographic, clinical, and laboratory findings were evaluated retrospectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: In children with autosomal dominant polycystic kidney disease (ADPKD), clinical manifestations range from severe neonatal presentation to renal cysts found by chance.
📊
Key Findings & Data:Materials and methods: We evaluated children diagnosed with ADPKD between January 2006 and January 2019.
💡
Conclusion & Impact:The demographic, clinical, and laboratory findings were evaluated retrospectively.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: In children with autosomal dominant polycystic kidney disease (ADPKD), clinical manifestations range from severe neonatal presentation to renal cysts found by chance. We aimed to evaluate demographic, clinical, laboratory findings, and genetic analysis of children with ADPKD. Materials and methods: We evaluated children diagnosed with ADPKD between January 2006 and January 2019. The diagnosis was established by family history, ultrasound findings, and/or genetic analysis. The demographic, clinical, and laboratory findings were evaluated retrospectively. Patients

🔖

Cite This Article

DEMİR, B. K., ALAYGUT, D., ALPARSLAN, C., SOYALTIN, E., MUTLUBAŞ, F., ÇAMLAR, S. A., YAVAŞCAN, Ö., ARYA, M., BERDELİ, A. (2022). Demographic and clinical characteristics of children with autosomal dominant polycystic kidney disease: a single center experience. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 2, 772–777. https://ajindex.com/articles/609952

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Reddy BV, Chapman AB. The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatric Nephrology 2017
  2. 32 (1): 31-42. doi: 10.1007/s00467-016- 3364-y 2. De Rechter S, Breysem L, Mekahli D. Is autosomal dominant polycystic kidney disease becoming a pediatric disorder? Frontiers in Pediatrics 2017
  3. doi: 10.3389/ fped.2017.00272 3. Fırıncı F, Soylu A, Kasap Demir B, Turkmen M, Kavukcu S. An 11-year-old child with autosomal dominant polycystic kidney disease who presented with nephrolithiasis. Case Reports in Medicine 2012: 428749. doi: 10.1155/2012/428749 4. Cachat F, Combescure C, Cauderay M, Girardin E, Chehade H. A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. Clinical Journal of the American Society of Nephrology 2015
  4. 10 (3): 382-389. doi: 10.2215/CJN.03080314 5. Gabow PA. Autosomal dominant polycystic kidney disease. New England Journal of Medicine 1993
  5. 329 (5): 332-342. doi: 10.1056/NEJM199307293290508 6. Reed B, McFann K, Kimberling WJ, Pei Y, Gabow PA et al. Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history. American Journal of Kidney Diseases 2008
  6. 52 (6): 1042-1050. doi: 10.1053/j.ajkd.2008.05.015 7. Dudley J, Winyard P, Marlais M, Cuthell O, Harris T et al. Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD). BMC Nephrology 2019
  7. 20 (1): 148. doi: 10.1186/s12882-019-1285-2 8. Golin CO, Johnson AM, Fick G, Gabow PA. Insurance for autosomal dominant polycystic kidney disease patients prior to end-stage renal disease. American Journal of Kidney Diseases 1996
  8. 27 (2): 220-223. doi: 10.1016/s0272- 6386(96)90544-2 9. Simms RJ, Thong KM, Dworschak GC, Ong AC. Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation 2016
  9. 31 (7): 1130-1140. doi: 10.1093/ndt/gfv299 10. Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney International 2015
  10. 88 (1): 17-27. doi: 10.1038/ki.2015.59 11. Gansevoort RT, Arici M, Benzing T, Birn H, Capasso G et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney diseas